share_log

Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24

Benzinga ·  08:35  · Ratings

Bernstein analyst William Pickering maintains Arrowhead Pharma (NASDAQ:ARWR) with a Market Perform and lowers the price target from $27 to $24.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment